ArticleOphthalmology and therapy2025

Real-World Outcomes of Brolucizumab Treatment in Japanese Patients with Neovascular Age-Related Macular Degeneration: A 12-Month, Multicenter Study.

Masayuki Ohnaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.